Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D05ZTJ
|
||||
| Drug Name |
Anileridine Hydrochloride
|
||||
| Synonyms |
Anileridine Phosphate; Leritine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Systemic pain [ICD10:R52, G89] | Approved | [551871] | ||
| Therapeutic Class |
Neurology Agents
|
||||
| Company |
Merck And Co Inc
|
||||
| Formula |
C22H30Cl2N2O2
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Mu-type opioid receptor | Target Info | Modulator | [556264] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | IL4-mediated signaling events | ||||
| References | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Tang and Dr. Mou.

